m-RNA Synthesis Service Market, By Application (Therapeutic Development, Vaccine Production, Drug Discovery, Others), By Scale of Operation (Research, Commercial), By End User (Biopharmaceutical Companies, Contract research organizations (CROs), Others), By Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)-

Published In : Feb 2023

Code : CMI5537

Pages :177

Formats :

Excel and PDF

Industry : Biotechnology

Leading Companies

Global m-RNA Synthesis Service Market- Driver

Increasing Facility Expansion by Market Players

Major companies operating in the global m-RNA synthesis service market are focused on organic growth strategies such as facility expansions, and this is expected to drive growth of the global m-RNA synthesis service market over the forecast period. For instance, in March 2021, Maravai LifeSciences, a global provider of life science reagents and services to researchers and biotech entrepreneurs, expanded its contract development and manufacturing organization (CDMO) capabilities at TriLink BioTechnologies, a division of Maravai LifeSciences, with the launch of its plasmid DNA (pDNA) manufacturing services. TriLink's new plasmid services will provide customers the convenience of a single-source messenger RNA (mRNA) solution, manufactured with Current Good Manufacturing Practice (cGMP) capabilities, from plasmid synthesis through final release testing

Global m-RNA Synthesis Service Market: Key Players

Major players operating in the global m-RNA synthesis service market include Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company, Creative Biogene, Kaneka Corporation, Danaher, eTheRNA, Biomay AG, ApexBio Technology, RiboPro, F. Hoffmann-La Roche Ltd, System Biosciences, LLC., Aurigene Pharmaceutical Services Ltd., OZ Biosciences, Aldevron and GenScript.